[SFGate] Gilead hepatitis C pill reaches $3.48 billion in quarterly sales
Jul 23, 2014
“The fundamental concern is Sovaldi and other speciality drugs are going… Read More
© 2024 CSRXP- All Rights Reserved
Updates
[NCHC] Earnings Report Shows Gilead Can Lower Sovaldi’s Unsustainable Price
Jul 23, 2014
Statement from the National Coalition on Health Care’s President and CEO… Read More
[SFGate] Costly hepatitis C drugs could add $300 to every American’s yearly premium, CVS says
Jul 21, 2014
Gilead Sciences’ new hepatitis C drug receives as much praise for its… Read More
[Market Watch] CVS officials say Sovaldi pricing in line with history, but unsustainable
Jul 20, 2014
Gilead Sciences’ controversial $1,000-a-day Sovaldi pill is priced in line… Read More
[SF Business Times ] Three takeaways from Gilead’s Hepatitis C challenge
Jul 18, 2014
1. It’s all about price — even when it’s not: Even before Foster… Read More
[The New York Times] $300,000 Drug
Jul 18, 2014
There is one other way that Kalydeco is an excellent example of personalized… Read More
[NCHC] Where is the Value in Overpricing Innovative Treatments?
Jul 17, 2014
At $1,000 per pill, the price of the new hepatitis C drug Sovaldi has… Read More
[WSJ] Will Gilead’s Hepatitis C Drug Bust State Budgets?
Jul 17, 2014
Will the cost of new hepatitis C treatments bust state budgets? A new analysis… Read More
[USA Today] Why $1,000 a pill? Our view
Jul 17, 2014
In the good-news/bad-news world of blockbuster drugs, the latest is the launch… Read More
[The Hill] Poll: 4 in 5 say $1,000-a-pill drug cost ‘unacceptable’
Jul 15, 2014
Eighty-two percent in a new poll say the cost of a $1,000-a-pill medicine… Read More
[The Washington Post] How do you pay for a drug that costs $84,000?
Jul 15, 2014
“As longtime health-care advocate John Rother sees it, the Sovaldi issue is… Read More
[Bloomberg News] U.S. Senators Ask Gilead to Explain $84,000 Hep C Drug Pricing
Jul 11, 2014
Gilead Sciences Inc. has been asked by two U.S. senators to explain how it… Read More